These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2867767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
    Kolassa N, Becker R, Wiener H.
    Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?
    Roediger WE, Millard S.
    Gut; 1995 Jan; 36(1):55-9. PubMed ID: 7890237
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ, Lo Casto M.
    Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
    [Abstract] [Full Text] [Related]

  • 7. Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon in vivo.
    Goerg KJ, Wanitschke R, Gabbert H, Breiling J, Franke M, Meyer zum Büschenfelde KH.
    Digestion; 1987 Mar; 37(2):79-87. PubMed ID: 2887473
    [Abstract] [Full Text] [Related]

  • 8. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kumamoto T, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
    Peskar BM, Dreyling KW, Peskar BA, May B, Goebell H.
    Agents Actions; 1986 Jun; 18(3-4):381-3. PubMed ID: 2875632
    [Abstract] [Full Text] [Related]

  • 12. Sulphasalazine, olsalazine and sulphapyridine induce mitogenic actions in the rat intestinal epithelium.
    Benno P, Alam M, Midtvedt T, Uribe A.
    APMIS; 1997 Sep; 105(9):717-22. PubMed ID: 9350216
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
    Naganuma M, Iwao Y, Ogata H, Inoue N, Funakoshi S, Yamamoto S, Nakamura Y, Ishii H, Hibi T.
    Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
    Craven PA, Pfanstiel J, Saito R, DeRubertis FR.
    Gastroenterology; 1987 Jun; 92(6):1998-2008. PubMed ID: 2883067
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y.
    Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM, Bartholomew TC, Jewell DP.
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.